Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FBCH5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,135
Award facts
- Contract value 100% obligated
- $10,135.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,135.19 to AmerisourceBergen Drug Corp for the supply of STELARA 45 MG/0.5 ML syringes (0.5 ML units), with an ultimate completion date of July 21, 2025. This firm fixed price delivery order, awarded on July 18, 2025, represents a competitive procurement with no set-aside designation. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The SPE2DX prime indefinite delivery vehicle functions as a comprehensive global pharmaceutical support contract enabling the company to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This delivery order for STELARA, a specialty pharmaceutical product, exemplifies the company's role in fulfilling specialized medical commodity needs within the DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FBCH5?
SPE2DB25FBCH5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FBCH5 worth?
The government has obligated $10,135 on SPE2DB25FBCH5.
Is contract SPE2DB25FBCH5 an order under another contract?
Yes. SPE2DB25FBCH5 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBCH5 competed?
The extent of competition for SPE2DB25FBCH5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award